Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Probiotics

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...

Oral Drug Delivery Systems: Delayed-Release Systems

Oral Drug Delivery Systems: Delayed-Release Systems

Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vaginal <i>Lactobacillus</i> spp. Dominance in Late Pregnancy and Neonatal Anthropometric Outcomes: A Prospective Observational Study.

Journal of clinical medicine·2026

Same author

Artificial Intelligence in Infectious Disease Care: Selected Applications in Tuberculosis, Sepsis, and Antimicrobial Stewardship.

Diagnostics (Basel, Switzerland)·2026

Same author

Challenges and recommendations in establishing national human diversity genomic projects.

Nature methods·2026

Same author

Biomimetic Response of Zr-2.5Nb Alloy to Artificial Saliva with Variable pH: Corrosion Behavior and Surface Adaptation.

Biomimetics (Basel, Switzerland)·2026

Same author

Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches.

Annals of medicine·2026

Same author

Diet-Oral Microbiota Interactions and Salivary Biomarkers of Nutritional Health: A Narrative Review.

Nutrients·2026

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

Biopolymer-Based Gel Capsules for Improved Probiotic Delivery.

Roxana Elena Gheorghita^1,2, Andrei Lobiuc², Mihai Covasa^2,3

¹Faculty of Medicine and Biological Sciences, Victor Babes University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.

Gels (Basel, Switzerland)

|March 27, 2026

Summary

Sodium alginate and wheat starch capsules effectively protect probiotics like Lacticaseibacillus rhamnosus and Bacillus clausii during digestion. This biopolymer system enhances survival and controlled release for functional foods and pharmaceuticals.

Keywords:

Bacillus clausii Lacticaseibacillus rhamnosus encapsulation sodium alginate starch

More Related Videos

Extraction of Plant-based Capsules for Microencapsulation Applications

Extraction of Plant-based Capsules for Microencapsulation Applications

Published on: November 9, 2016

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Related Experiment Videos

Last Updated: Mar 29, 2026

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

Extraction of Plant-based Capsules for Microencapsulation Applications

Extraction of Plant-based Capsules for Microencapsulation Applications

Published on: November 9, 2016

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Area of Science:

Biopolymer science
Food science
Microbiology

Background:

Biopolymer encapsulation improves probiotic stability and delivery.
Sodium alginate (SA) and wheat starch (ST) are promising biopolymers for encapsulation.

Purpose of the Study:

To develop SA-ST gel capsules for co-encapsulating Lacticaseibacillus rhamnosus and Bacillus clausii.
To evaluate the impact of polymer ratio and probiotic loading on capsule properties and in vitro performance.

Main Methods:

Extrusion-based fabrication of SA-ST capsules.
Characterization of capsule morphology, swelling, and encapsulation efficiency.
In vitro assessment of probiotic survival under simulated gastrointestinal conditions.

Main Results:

Capsule size was influenced by the SA:ST ratio, with higher ST content producing smaller capsules.
Encapsulation efficiency ranged from 71.2% to 96.7%, optimized at a 1:1 SA:ST ratio and higher probiotic loads.
SA-ST capsules significantly enhanced probiotic survival in simulated gastric and intestinal fluids, particularly ST-rich formulations.

Conclusions:

The SA-ST biopolymer system offers a scalable and cost-effective method for probiotic co-encapsulation.
These capsules provide synergistic protection, high encapsulation efficiency, and improved gastrointestinal stability for L. rhamnosus and B. clausii.
The developed system shows potential for applications in functional foods and pharmaceutical formulations.